08:30-09:15 Opening Session

E. Neri, Pisa/IT

09:15-10:45 State-of-the-Art Imaging 1

Moderators: S. Gourtsoyianni, Athens/GR; H-P. Schlemmer, Heidelberg/DE
09:15 Screening for HCC
L. Marti-Bonmati, Valencia/ES
09:45 What’s new in lymphoma imaging
M. Mayerhöfer, New York/US
10:15 Multiple myeloma imaging (WBMRI/WBCT)
T. Diallo, Freiburg/DE

10:45-11:15 Coffee Break

11:15-12:45 Multidisciplinary Team Session

Moderators: M. D’Anastasi, Msida/MT; A. Torregrosa Andrés, Valencia/ES
11:15 Hemato-oncology MDT meeting
D. Volterrani, Pisa/IT; E. Benedetti, Pisa/IT; M. Mayerhöfer, New York/US
12:00 Liver cancer MDT meeting
M. Brunetto, D. Cioni, L. Crocetti, P. De Simone; Pisa/IT

12:45-13:00 Break
13:00-14:00 Industry sponsored lunch symposium
14:00-14:30 Break

14:30-15:00 European Imaging Cancer Initiative

Moderators: E. Neri, Pisa/IT; R. Pintican, Cluj-Napoca/RO
14:30 EuCanImage project
K. Lekadir, Barcelona/ES
14:45 EUCAIM project
L. Marti-Bonmati, Valencia/ES

15:00-16:30 State-of-the-Art Imaging 2

Moderators: R. Lencioni, Pisa/IT; D. Leithner, New York/US
15:00 MRI for prostate imaging: Key points
V. Panebianco, Rome/IT
15:30 Reporting using RECIST criteria: Where are we now?
D. Regge, Turin/IT
16:00 Imaging the locally advanced rectal cancer patient
R. Beets-Tan, Amsterdam/NL

16:30-17:00 Coffee Break

17:00-18:00 Workshops

Workshop 1: MRI prostate reporting
D. Bonekamp, H-P. Schlemmer; Heidelberg/DE
GROUP A

Workshop 2: Liver cases
E. Chartampilas, Thessaloniki/GR; G. Aringhieri, Pisa/IT
GROUP B

Workshop 3: Rectal cancer treatement repsonse
S. Gourtsoyianni, Athens/GR; M. Rengo, Rome/IT
GROUP C

Workshop 4: RECIST reporting (choosing target and non target lesions)
G. Cappello, Candiolo/IT; M. D’Anastasi, Msida/MT
GROUP D

18:00-19:30 Poster Walking Tour & Welcome Reception

08:45-09:45 Workshops

Workshop 1: MRI prostate reporting
D. Bonekamp, H-P. Schlemmer; Heidelberg/DE
GROUP B

Workshop 2: Liver cases
E. Chartampilas, Thessaloniki/GR; G. Aringhieri, Pisa/IT
GROUP C

Workshop 3: Rectal cancer treatement repsonse
S. Gourtsoyianni, Athens/GR; M. Rengo, Rome/IT
GROUP D

Workshop 4: RECIST reporting (choosing target and non target lesions)
G. Cappello, Candiolo/IT; M. D’Anastasi, Msida/MT
GROUP A

09:45-10:15 Coffee Break

10:15-11:45 Reading, Reporting, Communication in oncologic imaging

Moderators: D. Cioni, Pisa/IT; M. Zerunian, Rome/IT
10:15 Head and neck cancers-NIRADS
D. Farina, Brescia/IT
10:45 Peritoneal carcinomatosis: Role of imaging in detection and treatment planning
M. Lahaye, Amsterdam/NL
11:15 Challenges in measuring immunotherapy response: iRECIST
L. Fournier, Paris/FR

11:45-12:00 Break
12:00-13:00 Industry sponsored lunch symposium
13:00-13:30 Break

13:30-14:30 ESOI meets Italian Chapter of Oncologic Imaging (SIRM)

Moderators: A. Giovagnoni, Ancona/IT; S. Cappabianca, Naples/IT
13:30 Oncologic Emergencies
M. Tonerini, Pisa/IT
13:50 Peritoneal carcinomatosis: Imaging challenges
M.A. Mazzei, Siena/IT
14:10 Imaging challenges in new therapy of lung cancer. Tips and tricks
S. Cappabianca, Naples/IT

14:30-16:00 Multidisciplinary Team Session

14:30 Head & Neck cancer MDT meeting
L. Faggioni, R. Marconcini, F. Paiar, V. Seccia; Pisa/IT
15:15 Lower GI tract cancer MDT meeting
G. Beets, Amsterdam/NL; G. Masi, Pisa/IT; D. Regge, Turin/IT

16:00-16:30 Coffee Break

16:30-17:30 Workshops

Workshop 1: MRI prostate reporting
D. Bonekamp, H-P. Schlemmer; Heidelberg/DE
GROUP C

Workshop 2: Liver cases
E. Chartampilas, Thessaloniki/GR; G. Aringhieri, Pisa/IT
GROUP D

Workshop 3: Rectal cancer treatement repsonse
S. Gourtsoyianni, Athens/GR; M. Rengo, Rome/IT
GROUP A

Workshop 4: RECIST reporting (choosing target and non target lesions)
G. Cappello, Candiolo/IT; M. D’Anastasi, Msida/MT
GROUP B

08:45-09:45 Workshops

Workshop 1: MRI prostate reporting
D. Bonekamp, H-P. Schlemmer; Heidelberg/DE
GROUP D

Workshop 2: Liver cases
E. Chartampilas, Thessaloniki/GR; G. Aringhieri, Pisa/IT
GROUP A

Workshop 3: Rectal cancer treatement repsonse
S. Gourtsoyianni, Athens/GR; M. Rengo, Rome/IT
GROUP B

Workshop 4: RECIST reporting (choosing target and non target lesions)
G. Cappello, Candiolo/IT; M. D’Anastasi, Msida/MT
GROUP C

09:45-10:00 Break

10:00-11:00 Scientific Sessions

11:00-11:30 Coffee Break

11:30-12:45 Special Hot Topics

Moderators: M. Polici, Rome/IT; M.F. Reiser, Munich/DE
11:30 New tracers in oncologic imaging
C. Cyran, Munich/DE
11:55 AI in oncologic imaging
S. Morozov, Liège/BE
12:20 Radiomics for treatment assessment
E. Sala, Cambridge/UK

12:45-13:00 Closing + Awarding Session

E. Neri, Pisa/IT

We have the honour and the pleasure to invite you to the ESOI Annual Scientific Meeting 2023, in Pisa, Italy.
After a successful meeting in Dubrovnik in 2022 we are looking forward to offering you again attractive and interesting opportunities to become part of this subspecialty congress.
Various options within an exciting scientific & educational programme focusing on oncologic imaging shall help to perfectly position your company and reach about 300 expected international participants.

Supporting ESOI 2023 Pisa – What’s in for the industry?
› Participate and present your products and research in the exhibition to an international audience
› Stimulate and discuss new research: Use the unique debates concept to stir discussion and create awareness
› Encourage and promote education and public awareness
› Cooperate and network with opinion leaders
› Support and assist opinion leaders to reach the best clinical recommendations for current therapeutic dilemmas
› Inform and update international participants on clinical and technological developments

Besides our standard options, we will be happy to create your very own sponsor package or discuss further/other options that might be interesting to your company.

We would be delighted to welcome you as a partner of the ESOI Annual Scientific Meeting 2023, in Pisa, Italy.

On behalf of the Organising Committee we wish you a memorable meeting.
Prof. Emanuele Neri, Pisa, Italy
ESOI President

> For detailed information on the sponsor options of this year’s congress, please contact the ESOI Office via office@esoi-society.org.

AIFA – Requests for authorisation of conferences and meetings in Italy
https://www.aifa.gov.it/en/web/guest/acc
Any Italian or foreign marketing authorisation holder (or company engaged in the marketing of pharmaceuticals based on an agreement with the respective MAH), wishing to organise or participate in the organisation of a conference or a meeting on topics related to the use of pharmaceuticals, should submit to AIFA a request for authorisation of a proposed conference or meeting, whose technical nature will be then assessed by AIFA.
This is in line with article 124 of Italian legislative decree 219/2006.
As per paragraph 2, we have chosen the following partner
Atlante Viaggi Italia Srl
Via Bandello, 1
20123 Milano
Barbara.Mantegazza@atlanteviaggi.com

As per Italian law,
the AIFA authorization is necessary
• for each pharmaceutical company (with Marketing Authorization Holder or the companies responsible for the actual marketing of pharmaceutical products) sponsoring the congress on topics in any way related to the use of its own pharmaceutical products.
The AIFA authorization is not necessary
• when a company promotes by advertising only medical devices or food supplements during a congress (products without Marketing Authorization)
• when a company sponsors a meeting about topics not related to the use of any of its own medicinal products; in this case the company is not allowed to expose or distribute any kind of advertising material during the meeting (Section 9 art. 124 D.L. n.219/06)

Any pharmaceutical company that sponsors a congress on topics related to the use of its pharmaceutical products, must apply to the competent unit of the Italian Medicines Agency (AIFA) to obtain a specific authorization. If your pharmaceutical company has a marketing authorization (MAH or AIC) or the companies responsible for the effective marketing of your pharmaceutical products and sponsor the congress on topics related to the use of your pharmaceutical products, you should contact Atlante Viaggi communicating your SIS code, by 15 June 2023: barbara.mantegazza@atlanteviaggi.com.
If you don’t have a SIS code yet, we recommend that you contact your Italian branch, your regulatory office or your representative in Italy as soon as possible, to start the procedure to obtain the SIS code necessary to be included in the procedure by 15 June or have more information on Italian legislation.

We cordially thank the ESOI 2023 industry partners for their valuable support: